Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head
Clinical trial NCT01611480 · COMPLETED
Trial details
- NCT number
- NCT01611480
- Sponsor
- Moberg Pharma AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2013-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.